| pubmed-article:17205304 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0205208 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:17205304 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:17205304 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17205304 | pubmed:dateCreated | 2007-8-10 | lld:pubmed |
| pubmed-article:17205304 | pubmed:abstractText | To explore the pharmacokinetics (PKs) of paclitaxel and two major metabolites after three single oral administrations of a novel drinking solution and two capsule formulations in combination with cyclosporin A (CsA) in patients with advanced cancer. Moreover, the tolerability and safety of the formulations was studied. In addition, single nucleotide polymorphisms in the multidrug resistance (MDR1) gene were determined. | lld:pubmed |
| pubmed-article:17205304 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17205304 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205304 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17205304 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205304 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205304 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205304 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205304 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17205304 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:17205304 | pubmed:issn | 0344-5704 | lld:pubmed |
| pubmed-article:17205304 | pubmed:author | pubmed-author:FetellM RMR | lld:pubmed |
| pubmed-article:17205304 | pubmed:author | pubmed-author:BeijnenJ HJH | lld:pubmed |
| pubmed-article:17205304 | pubmed:author | pubmed-author:RosingHH | lld:pubmed |
| pubmed-article:17205304 | pubmed:author | pubmed-author:HuS TST | lld:pubmed |
| pubmed-article:17205304 | pubmed:author | pubmed-author:SchellensJ... | lld:pubmed |
| pubmed-article:17205304 | pubmed:author | pubmed-author:HuitemaA D... | lld:pubmed |
| pubmed-article:17205304 | pubmed:author | pubmed-author:VeltkampS ASA | lld:pubmed |
| pubmed-article:17205304 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17205304 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:17205304 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17205304 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17205304 | pubmed:pagination | 635-42 | lld:pubmed |
| pubmed-article:17205304 | pubmed:dateRevised | 2007-11-30 | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:meshHeading | pubmed-meshheading:17205304... | lld:pubmed |
| pubmed-article:17205304 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17205304 | pubmed:articleTitle | Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours. | lld:pubmed |
| pubmed-article:17205304 | pubmed:affiliation | Division of Experimental Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, Amsterdam, The Netherlands. s.veltkamp@nki.nl | lld:pubmed |
| pubmed-article:17205304 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17205304 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17205304 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17205304 | lld:pubmed |
